Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Maravai LifeSciences Holdings Inc
Operating Income
Maravai LifeSciences Holdings Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
|
Operating Income
-$25.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Operating Income
$661.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
15%
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Maravai LifeSciences Holdings Inc's Operating Income?
Operating Income
-25.2m
USD
Based on the financial report for Dec 31, 2023, Maravai LifeSciences Holdings Inc's Operating Income amounts to -25.2m USD.